SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q1 2019 13F Holders as of 31 Mar 2019
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 11,866,163
- Share change
- -83,292
- Total reported value
- $76,776,000
- Price per share
- $6.47
- Number of holders
- 20
- Value change
- -$565,886
- Number of buys
- 5
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
8.2%
|
5,900,000
|
$40,946,000 | — | 31 Dec 2018 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4%
|
2,839,500
|
$19,706,000 | — | 31 Dec 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
2,388,573
|
$16,577,000 | — | 31 Dec 2018 | |
| Neumann Advisory Hong Kong Ltd |
13F
|
Company |
0.44%
|
315,586
|
$2,190,000 | — | 31 Dec 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
141,512
|
$982,000 | — | 31 Dec 2018 | |
| Sapphire Star Partners LP |
13F
|
Company |
0.14%
|
104,014
|
$722,000 | — | 31 Dec 2018 | |
| Yorktown Management & Research Co Inc |
13F
|
Company |
0.1%
|
74,893
|
$520,000 | — | 31 Dec 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
68,732
|
$477,000 | — | 31 Dec 2018 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.06%
|
41,733
|
$290,000 | — | 31 Dec 2018 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
34,017
|
$236,000 | — | 31 Dec 2018 | |
| Spark Investment Management LLC |
13F
|
Company |
0.04%
|
29,100
|
$201,000 | — | 31 Dec 2018 | |
| NAVELLIER & ASSOCIATES INC |
13F
|
Company |
0.04%
|
28,953
|
$201,000 | — | 31 Dec 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,717
|
$192,000 | — | 31 Dec 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
22,374
|
$155,000 | — | 31 Dec 2018 | |
| RAMSEY QUANTITATIVE SYSTEMS |
13F
|
Company |
0.02%
|
12,159
|
$84,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
8,552
|
$60,000 | — | 31 Dec 2018 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.01%
|
6,146
|
$43,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
5,000
|
$35,000 | — | 31 Dec 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,672
|
$12,000 | — | 31 Dec 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,250
|
$9,000 | — | 31 Dec 2018 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
1,200
|
$8,328 | — | 31 Dec 2018 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1,000
|
$7,000 | — | 31 Dec 2018 | |
| CWM, LLC |
13F
|
Company |
0%
|
500
|
$3,000 | — | 31 Dec 2018 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
412
|
$3,000 | — | 31 Dec 2018 | |
| Financial Gravity Companies, Inc. |
13F
|
Company |
0%
|
399
|
$3,000 | — | 31 Dec 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
335
|
$2,000 | — | 31 Dec 2018 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
150
|
$1,000 | — | 31 Dec 2018 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2019
As of 31 Mar 2019,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,866,163 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GEODE CAPITAL MANAGEMENT, LLC, RAMSEY QUANTITATIVE SYSTEMS, and NORTHERN TRUST CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
27
Q1 2019 holders
20
Holder diff
-7
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.